Heart failure therapy in children

References

• Eskedal L, Hagemo PS, Eskild A, Aamodt G, Seiler KS, Thaulow E. Survival after surgery for congenital heart defects: does reduced early mortality predict improved long-term survival? Acta. Paediatr. 94(4), 438–443 (2005).
   PubMed Web of Science ®Google Scholar
• Fredriksen PM, Veldtman G, Hechter S et al. Aerobic capacity in adults with various congenital heart diseases. Am. J. Cardiol. 87(3), 310–314 (2001).
   PubMed Web of Science ®Google Scholar
• Hjortdal VE, Stenbog EV, Ravn HB et al. Neurohormonal activation late after cavopulmonary connection. Heart 83(4), 439–443 (2000).
   PubMed Web of Science ®Google Scholar
• Iivainen TE, Groundstroem KW, Lahtela JT, Talvensaari TJ, Pasternack A, Uusitalo A. Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect. Eur. J. Heart Fail. 2(2), 161–165 (2000).
   PubMed Web of Science ®Google Scholar
• Rosenthal D, Chrisant MR, Edens E et al. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J. Heart Lung Transplant. 23(12), 1313–1333 (2004).
   PubMed Web of Science ®Google Scholar
• Ross RD. Grading the graders of congestive heart failure in children. J. Pediatr. 138(5), 618–620 (2001).
   PubMed Web of Science ®Google Scholar
• Andrew P. Diastolic heart failure demystified. Chest 124(2), 744–753 (2003).
   PubMed Web of Science ®Google Scholar
• Rudolph AM. Myocardial growth before and after birth: clinical implications. Acta Paediatr. 89(2), 129–133 (2000).
   PubMed Web of Science ®Google Scholar
• Boucek RJ Jr, Shelton ME, Artman M, Landon E. Myocellular calcium regulation by the sarcolemmal membrane in the adult and immature rabbit heart. Basic Res. Cardiol. 80(3), 316–325 (1985).
   PubMed Web of Science ®Google Scholar
• Chin TK, Friedman WF, Klitzner TS. Developmental changes in cardiac myocyte calcium regulation. Circ. Res. 67(3), 574–579 (1990).
   PubMed Web of Science ®Google Scholar
• Erath HG Jr, Boerth RC, Graham TP Jr. Functional significance of reduced cardiac sympathetic innervation in the newborn dog. Am. J. Physiol. 243(1), H20–H26 (1982).
   Google Scholar
• Friedman WF, Pool PE, Jacobowitz D, Seagren SC, Braunwald E. Sympathetic innervation of the developing rabbit heart. Biochemical and histochemical comparisons of fetal, neonatal, and adult myocardium. Circ. Res. 23(1), 25–32 (1968).
   PubMed Web of Science ®Google Scholar
• Ostman-Smith I. Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat. Br. J. Pharmacol. 116(6), 2703–2709 (1995).
   PubMed Web of Science ®Google Scholar
• deVries WB, van der Leij FR, Bakker JM et al. Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatr. Res. 52(6), 900–906 (2002).
   PubMed Web of Science ®Google Scholar
• Bolger AP, Sharma R, Li W M et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106(1), 92–99 (2002).
   PubMed Web of Science ®Google Scholar
• Davos CH, Davlouros PA, Wensel R et al. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation 106(12 Suppl. 1), I69–I75 (2002).
   PubMed Web of Science ®Google Scholar
• Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur. Heart J. 26(5), 433–439 (2005).
   PubMed Web of Science ®Google Scholar
• Boudjemline Y, Bonhoeffer P. Percutaneous valve replacement: a fad or an advance? Nature Clin. Pract. Cardiovasc. Med. 1(2), 62–63 (2004).
   PubMedGoogle Scholar
• English RF, Janosky JE, Ettedgui JA, Webber SA. Outcomes for children with acute myocarditis. Cardiol. Young. 14(5), 488–493 (2004).
   PubMed Web of Science ®Google Scholar
• Hornung TS, Bernard EJ, Jaeggi ET, Howman-Giles RB, Celermajer DS, Hawker RE. Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries. Heart 80(4), 322–326 (1998).
   PubMed Web of Science ®Google Scholar
• Ross RD, Daniels SR, Schwartz DC, Hannon DW, Shukla R, Kaplan S. Plasma norepinephrine levels in infants and children with congestive heart failure. Am. J. Cardiol. 59(8), 911–914 (1987).
   PubMed Web of Science ®Google Scholar
• Warnes CA, Somerville J. Tricuspid atresia with transposition of the great arteries in adolescents and adults: current state and late complications. Br. Heart J. 57(6), 543–547 (1987).
   PubMedGoogle Scholar
• Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J. Pediatr. 138(5), 644–648 (2001).
   PubMed Web of Science ®Google Scholar
• Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J. Heart Lung Transplant. 21(2), 189–203 (2002).
   PubMed Web of Science ®Google Scholar
• Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J. Card. Fail. 11(5 Suppl.), S76–S80 (2005).
   Google Scholar
• Ishii H, Harada K, Toyono M, Tamura M, Takada G. Usefulness of exercise-induced changes in plasma levels of brain natriuretic peptide in predicting right ventricular contractile reserve after repair of tetralogy of Fallot. Am. J. Cardiol. 95(11), 1338–1343 (2005).
   PubMed Web of Science ®Google Scholar
• Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM. Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects. J. Thorac. Cardiovasc. Surg. 129(5), 1104–1110 (2005).
   PubMed Web of Science ®Google Scholar
• Vogel M, Derrick G, White PA et al. Systemic ventricular function in patients with transposition of the great arteries after atrial repair: a tissue Doppler and conductance catheter study. J. Am. Coll. Cardiol. 43(1), 100–106 (2004).
   PubMed Web of Science ®Google Scholar
• Edelman RR. Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 232(3), 653–668 (2004).
   PubMed Web of Science ®Google Scholar
• Kimball TR, Daniels SR, Meyer RA et al. Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect. Am. J. Cardiol. 68(13), 1377–1382 (1991).
   PubMed Web of Science ®Google Scholar
• Berman W Jr, Yabek SM, Dillon T, Niland C, Corlew S, Christensen D. Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect. N. Engl. J. Med. 308(7), 363–366 (1983).
   PubMed Web of Science ®Google Scholar
• Seguchi M, Nakazawa M, Momma K. Further evidence suggesting a limited role of digitalis in infants with circulatory congestion secondary to large ventricular septal defect. Am. J. Cardiol. 83(9), 1408–1411, A8 (1999).
   PubMed Web of Science ®Google Scholar
• Hobbins SM, Fowler RS, Rowe RD, Korey AG. Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease. Arch. Dis. Child 56(12), 934–938 (1981).
   PubMed Web of Science ®Google Scholar
• Grenier MA, Fioravanti J, Truesdell SC, Mendelsohn AM, Vermilion RP, Lipshultz SE. Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review. Prog. Pediatr. Cardiol. 12(1), 91–111 (2000).
   PubMedGoogle Scholar
• Leversha AM, Wilson NJ, Clarkson PM, Calder AL, Ramage MC, Neutze JM. Efficacy and dosage of enalapril in congenital and acquired heart disease. Arch. Dis. Child 70(1), 35–39 (1994).
   PubMed Web of Science ®Google Scholar
• Vazquez-Antona CA, Simon RS, Rijlaarsdam M et al. Oral enalapril in patients with symptomatic ventricular septal defects. Arch. Inst. Cardiol. Mex. 66(6), 496–504 (1996).
   PubMedGoogle Scholar
• Shaddy RE, Curtin EL, Sower B et al. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design. Am. Heart J. 144(3), 383–389 (2002).
   PubMed Web of Science ®Google Scholar
• Webster MW, Neutze JM, Calder AL. Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts. Pediatr. Cardiol. 13(3), 129–135 (1992).
   PubMed Web of Science ®Google Scholar
• Rokicki W, Borowicka E. Use of converting angiotensin inhibitors in children. II. Personal experience with enalapril. Wiad. Lek. 50(4–6), 85–93 (1997).
   PubMedGoogle Scholar
• Bendig L, Temesvari A. Indications and effects of captopril therapy in childhood. Acta Physiol. Hung. 72(Suppl.), 121–129 (1988).
   PubMedGoogle Scholar
• Lewis AB, Chabot M. The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy. Pediatr. Cardiol. 14(1), 9–12 (1993).
   PubMed Web of Science ®Google Scholar
• Balaguru D, Auslender M. Vasodilators in the treatment of pediatric heart failure. Prog. Pediatr. Cardiol. 12(1), 81–90 (2000).
   PubMedGoogle Scholar
• Ellis D, Moritz ML, Vats A, Janosky JE. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders. Am. J. Hypertens. 17(10), 928–935 (2004).
   PubMed Web of Science ®Google Scholar
• Rusconi P, Gomez-Marin O, Rossique-Gonzalez M et al. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution. J. Heart Lung Transplant. 23(7), 832–838 (2004).
   PubMed Web of Science ®Google Scholar
• Williams RV, Tani LY, Shaddy RE. Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. J. Heart Lung Transplant. 21(8), 906–909 (2002).
   PubMed Web of Science ®Google Scholar
• Bruns LA, Chrisant MK, Lamour JM et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J. Pediatr. 138(4), 505–511 (2001).
   PubMed Web of Science ®Google Scholar
• Buchhorn R, Hulpke-Wette M, Hilgers R, Bartmus D, Wessel A, Bursch J. Propranolol treatment of congestive heart failure in infants with congenital heart disease: the CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol. Int. J. Cardiol. 79(2–3), 167–173 (2001).
   PubMed Web of Science ®Google Scholar
• Shaddy RE, Tani LY, Gidding SS et al. β-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J. Heart Lung Transplant. 18(3), 269–274 (1999).
   PubMed Web of Science ®Google Scholar
• Laitinen P, Happonen JM, Sairanen H et al. Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect. J. Cardiothorac. Vasc. Anesth. 11(7), 870–874 (1997).
   PubMed Web of Science ®Google Scholar
• Laitinen P, Ahonen J, Olkkola KT, Peltola K, Rautiainen P, Rasanen J. Pharmacokinetics of amrinone in neonates and infants. J. Cardiothorac. Vasc. Anesth. 14(4), 378–382 (2000).
   PubMed Web of Science ®Google Scholar
• Hoffman TM, Wernovsky G, Atz AM et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics. Am. Heart J. 143(1), 15–21 (2002).
   PubMed Web of Science ®Google Scholar
• Bailey JM, Hoffman TM, Wessel DL et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J. Pharmacokinet. Pharmacodyn. 31(1), 43–59 (2004).
   PubMed Web of Science ®Google Scholar
• Latifi S, Lidsky K, Blumer JL. Pharmacology of inotropic agents in infants and children. Prog. Pediatr. Cardiol. 12(1), 57–79 (2000).
   PubMedGoogle Scholar
• Turanlahti M, Boldt T, Palkama T, Antila S, Lehtonen L, Pesonen E. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr. Crit. Care Med. 5(5), 457–462 (2004).
   PubMedGoogle Scholar
• Braun JP, Schneider M, Dohmen P, Dopfmer U. Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support. J. Cardiothorac. Vasc. Anesth. 18(6), 772–774 (2004).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Teerlink JR, Mebazaa A. Pharmacology of new agents for acute heart failure syndromes. Am. J. Cardiol. 96(6A), 68G–73G (2005).
   Web of Science ®Google Scholar
• Follath F, Cleland JG, Just H et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study), a randomised double-blind trial. Lancet 360(9328), 196–202 (2002).
   PubMed Web of Science ®Google Scholar
• Mahle WT, Cuadrado AR, Kirshbom PM, Kanter KR, Simsic JM. Nesiritide in infants and children with congestive heart failure. Pediatr. Crit. Care Med. 6(5), 543–546 (2005).
   PubMedGoogle Scholar
• Sehra R, Underwood K. Nesiritide use for critically ill children awaiting cardiac transplantation. Pediatr. Cardiol. (2005) (Epub ahead of print).
   Google Scholar
• Smith RR, Wray J, Khaghani A, Yacoub M. Ten year survival after paediatric heart transplantation: a single centre experience. Eur. J. Cardiothorac. Surg. 27(5), 790–794 (2005).
   PubMed Web of Science ®Google Scholar
• Khairy P, Fournier A, Thibault B, Dubuc M, Therien J, Vobecky SJ. Cardiac resynchronization therapy in congenital heart disease. Int. J. Cardiol. (2005) (Epub ahead of print).
   PubMedGoogle Scholar